IDEAYA Biosciences', a developmental biotech, valuation declined over 50% since mid-2024. Check out why I'm coming away with ...

Gencor's rising revenues, growing cash balance, and debt-free status suggest an overreaction by the market. Read why GENC ...

Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) assets have changed considerably in recent years. Today, the value of Berkshire's controlled companies exceeds its public equity portfolio. Berkshire ...

ArcWest Exploration Inc. (TSXV: AWX) ("ArcWest") is pleased to report results from the Company's first phase drill program at ...

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...

Mural Oncology plc said on Tuesday it would stop clinical development of its lead cancer treatment, nemvaleukin, and look into strategic alternatives for the company.

Over the last century, no asset class has come particularly close to outpacing the average annual return of the stock market.

Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will ...

Mural Oncology (MURA) announced that following review of data from its phase 2 ARTISTRY-6 trial in melanoma and previously announced results ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for safety and defense tech applications, today announced preliminary ...

April 15, 2025 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and ...